BioTelemetry, Inc. Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P 500 volatile in choppy trading; Mideast deal, SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil nears two-month lows on reports of imminent US-Iran peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
BioTelemetry (BEAT) Tops Q1 EPS by 1c; Raises Revenue Otulook
April 25, 2019 4:08 PM EDTBioTelemetry (NASDAQ: BEAT) reported Q1 EPS of $0.42, $0.01 better than the analyst estimate of $0.41. Revenue for the quarter came in at $104 million versus the consensus estimate of $104.11 million.
Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, Inc., commented: The first quarter was another great quarter with record revenue and a strong adjusted EBITDA margin, both of which were in line with our expectations.... More
